= Solution
\b[Rodents and primates form homologous early lineages, but their developmental schedules and some regulatory dependencies differ.] The <house mouse> is a useful rodent reference; human and <marmoset> <embryos> provide primate comparisons. Neither one rodent nor one primate represents every member of its group. Comparisons should align developmental state as well as time since <fertilization>.
Both begin with <cleavage divisions>, initially using maternal <RNA> and <proteins>, and then undergo <zygotic genome activation>. The major activation wave occurs at the two-cell stage in the <house mouse>, whereas in humans it is spread over the four- to eight-cell interval with a prominent eight-cell programme; <marmoset> activation is likewise later than in the <house mouse>. Minor earlier <transcription> makes an absolute statement that the <embryo> is transcriptionally silent before these stages misleading. Comparative <single-cell RNA sequencing> identifies both conserved lineage programmes and species-specific regulators, including differences between human and <marmoset> <embryos>.<Single cell transcriptome analysis of human, marmoset and mouse embryos reveals common and divergent features of preimplantation development by Thorsten Boroviak and others>[Development 145, dev167833; early cleavage-stage comparisons and lineage-specific transcription-factor analyses]{ref}
The timing difference can be demonstrated with stage-resolved nascent-<RNA> labeling, intronic <RNA> measurements and <transcription> inhibition, alongside maternal-transcript decay measurements. Increased total transcript abundance alone cannot distinguish new synthesis from altered stability. An inhibitor-induced cleavage arrest is informative only if uptake, target engagement and viability are checked; maternal stores may sustain divisions after inhibition. Species-specific rates of division also mean that two-cell versus eight-cell activation cannot be translated into a fixed hour difference without direct measurement.
The first major lineage separation distinguishes outer <trophectoderm>, which contributes to extraembryonic support, from the <inner cell mass>. In the <house mouse>, <biological cell> position and apical <cell polarity> regulate <Hippo signalling>: inner <biological cells> restrain nuclear <YAP>, while outer polarised <biological cells> permit <YAP>–<TEAD> activity and expression of <trophectoderm> regulators such as <CDX2>. <OCT4>, <Sox2> and <NANOG> participate in pluripotent identity. Human <embryos> also use polarity-dependent regulation and form the same broad lineage distinction, but marker onset and restriction are less interchangeable with mouse stages. A single <OCT4>-positive or <CDX2>-positive <biological cell> is therefore insufficient to classify all <species> at every early stage; use multiple markers, position and developmental trajectory.<Initiation of a conserved trophectoderm program in human, cow and mouse embryos by Claudia Gerri and others>[Nature 587, pp. 443–447; comparative polarity, Hippo-pathway activity and trophectoderm initiation]{ref}
The <inner cell mass> subsequently separates into <epiblast>, which supplies the <embryo> proper, and <hypoblast>, also called <primitive endoderm>, which supplies extraembryonic endodermal <biological tissues>. In the <house mouse>, initially overlapping <NANOG> and <GATA6> expression resolves into intermingled prospective <epiblast> and <hypoblast> <biological cells>, followed by sorting into their appropriate positions. Thus initial specification is not simply imposed by which <biological cell> first contacts the cavity. <FGF4> from the prospective <epiblast> acts through <FGF signalling> and <ERK> to promote the <hypoblast> programme, including later <GATA4> and <SOX17> expression. Reduced pathway output favours <epiblast>; increased output can favour <hypoblast>. Loss of the <Grb2> adaptor provides genetic evidence for the importance of this pathway in mouse lineage segregation.<Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway by Claire Chazaud and others>[Developmental Cell 10, pp. 615–624: Grb2 mutants, NANOG/GATA6 segregation and lineage allocation]{ref}
For the evidence available at the June 2025 examination, the central contrast was that <hypoblast> markers persisted in human <embryos> exposed to <FGF receptor> or <MEK> inhibitors under conditions that strongly redirected rodent <inner cell mass> allocation. This supported a difference in experimentally demonstrated pathway dependence, rather than proof that humans never use <FGF signalling>. Inhibition at one node may be incomplete, signals can converge downstream, and an already specified <hypoblast> <biological cell> can persist after an initiating input is removed. The original comparative inhibitor experiments should therefore be interpreted in their stage and culture context.<Human hypoblast formation is not dependent on FGF signalling by Mila Roode and others>[Figure 2 and accompanying Results: human versus mouse and rat responses to FGF/MEK inhibition]{ref}
There are additional primate features. Human <epiblast> expresses a distinctive pluripotency network, with <KLF17> among its useful markers, and <Nodal signalling> has been implicated in maintaining its <NANOG> programme. Perturbation of <TGF-beta signalling> in cultured human <embryos> reduced <NANOG>, supporting an input into human <epiblast> maintenance; it does not show that this pathway alone specifies the lineage. Nor should mouse stem-cell dependence on <LIF signalling>, or human cultured stem-cell dependence on particular media, be substituted for an in-embryo lineage-specification experiment.<Defining the three cell lineages of the human blastocyst by single-cell RNA-seq by Paul Blakeley and others>[Results: human epiblast-enriched transcription and TGF-beta signalling inhibition in human embryos]{ref}
Morphogenesis also diverges. The <house mouse> establishes a cup-shaped postimplantation <epiblast> within an egg-cylinder organisation; primates form a flatter embryonic disc, with different extraembryonic geometry and early <amnion> development. Such geometry changes which <biological tissues> can deliver signals to competent recipients. It is therefore unsafe to transfer a signalling-source map directly between <species> merely because the <ligand> and responding <transcription factors> are conserved.
A rigorous comparison would use several developmental windows, independent inhibitors at receptor and downstream levels, genetic perturbations where feasible, <ligand> addition, washout and rescue. Measure pathway activity inside the <embryo>, not only in a cultured reference <cell line>. Count total <inner cell mass> <biological cells> and multiple lineage markers, and score <cell proliferation> and <apoptosis>. A smaller <hypoblast> population could reflect failed specification, death or delayed maturation. Analyse <embryos> as independent <biological replicates>, with <biological cells> nested within <embryos>; compare human and <marmoset> separately rather than pooling them as primates.
A later result sharpens the caveat. Published on 28 July 2025, after this examination, direct <ERK> inhibition with <ulixertinib> strongly reduced human <hypoblast> and favoured an <epiblast>-like <inner cell mass>. This revises the strongest reading of the older pharmacological contrast: \b[shared ERK dependence can coexist with different upstream inhibitor responses and different downstream pluripotency programmes.] It is a subsequent scientific update, not evidence a June candidate was expected to know.<Suppression of ERK signalling promotes pluripotent epiblast in the human blastocyst by Claire S. Simon and others>[Publication date; Figure 2 and Results, Suppression of ERK signalling blocks hypoblast formation in the human blastocyst]{ref}
Back to article page
